Chemical Compound
[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
CAS Registry Number
8075-78-3
Primary record
[(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 库存
- 4,327 克
- 纯度
- 99.6 %
- CAS
- 8075-78-3
化合物标识与属性
- CAS
- 8075-78-3
- PubChem CID
- 66466
- SMILES
- CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
- Canonical SMILES
- C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C.C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C
名称与同义词
- Bisecurin
- Demulen
- Lestrin
- Bisecurin II
- Kelnor
- Zovia
- Conova 30
- Ovamin 30
- Ovulen 30
- Ovulen-50
- Ovulen 50
- Kelnor 1/35
- MALMOREDE
- LO-MALMOREDE
- RefChem:56823
- ZOVIA 1/35E-28
- ZOVIA 1/50E-28
- DEMULEN 1/35-21
- DEMULEN 1/35-28
- DEMULEN 1/50-21
- DEMULEN 1/50-28
- AC1L25FO
- SC 11800 EE
- SC-11800 EE
- ZOVIA 1/35E-21
- ZOVIA 1/50E-21
- Ethynodiol Diacetate and Ethinyl Estradiol
- DTXSID701001456
- SCHEMBL4436615
- SCHEMBL29560729
- STZJJZZLAXIFHB-DIRPKPHOSA-N
- CID66466
- CID:66466
- C24H28O4.C20H24O2
- Ethinyl estradiol; ethynodiol diacetate
- Ethynodiol diacetate mixt. with ethynylestradiol
- Ethynylestradiol mixt. with ethynodiol diacetate
- 8075-78-3
- Ethinyl estradiol mixture with ethynodiol diacetate
- LS-97367
- SID:134222627
- ETHINYL ESTRADIOL/ETHYNODIOL DIACETATE
- ETHINYL ESTRADIOL;ETHYNODIOL DIACETATE
- ETHYNODIOL DIACETATE/ETHINYL ESTRADIOL
- ETHYNODIOL DIACETATE;ETHINYL ESTRADIOL
- C24-H32-O4.C20-H24-O2
- ETHINYL ESTRADIOL / ETHYNODIOL DIACETATE
- ETHYNODIOL DIACETATE / ETHINYL ESTRADIOL
- C021601
- (17 alpha)-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol, mixt. with (3 beta,17 alpha)-19-norpregn-4-en-20-yne-3,17-diol diacetate
- (17alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, mixt. with (3beta,17alpha)-19-norpregn-4-en-20-yne-3,17-diol diacetate
- [(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17-alpha)-, mixt. with (3-beta,17-alpha)-19-norpregn-4-en-20-yne-3,17-diyl diacetate
- 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alph)-, mixt. with (3beta,17alpha)-19-norpregn-4-en-20-yne-3,17-diyl-diacetate
- [(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- [(3S,8R,9S,10R,13S,14S,17R)-17-Acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetate;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14
- [(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]acetate;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
- 19-Norpregn-4-en-20-yne-3,17-diyl diacetate--19-norpregna-1(10),2,4-trien-20-yne-3,17-diol (1/1)
- 3beta,17alpha-19-Norpregn-4-en-20-yne-3,17-diyl diacetate--17alpha-19-norpregna-1(10),2,4-trien-20-yne-3,17-diol (1/1)